QUICK SPARK: Martin Shkreli Shorts Hims & Hers Stock, Says 'Peptides Are Fake Medicine'

Martin Shkreli said he is short Hims & Hers Health (HIMS) and criticized its peptide products as illegitimate medicine. While no financial figures or guidance changes were provided, the allegations and active short position raise regulatory/credibility overhang that could pressure sentiment and the stock near-term.

Analysis

Martin Shkreli said he is short Hims & Hers Health (HIMS) and criticized its peptide products as illegitimate medicine. While no financial figures or guidance changes were provided, the allegations and active short position raise regulatory/credibility overhang that could pressure sentiment and the stock near-term.